Search Results - "Kanjanabuch, T"

Refine Results
  1. 1
  2. 2

    PPAR-γ agonist protects podocytes from injury by Kanjanabuch, T., Ma, L.-J., Chen, J., Pozzi, A., Guan, Y., Mundel, P., Fogo, A.-B.

    Published in Kidney international (01-06-2007)
    “…Podocyte injury and loss contribute to progressive glomerulosclerosis. Peroxisome proliferator-activated receptor-γ (PPAR-γ) is a nuclear hormone receptor,…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Efficacy of enteric-coated mycophenolate sodium in patients with resistant-type lupus nephritis: a prospective study by Traitanon, O, Avihingsanon, Y, Kittikovit, V, Townamchai, N, Kanjanabuch, T, Praditpornsilpa, K, Wongchinasri, J, Tungsanga, K, Eiam-Ong, S

    Published in Lupus (01-08-2008)
    “…The role of mycophenolate mofetil (MMF) is still controversial in the treatment of cyclophosphamide-resistant proliferative lupus nephritis (PLN)…”
    Get full text
    Journal Article
  7. 7

    Continental variations in IgA nephropathy among Asians by Prakash, S, Kanjanabuch, T, Austin, P C, Croxford, R, Hsu, C-Y, Choi, A I, Cattran, D C

    Published in Clinical nephrology (01-11-2008)
    “…Local variations in patient demographics and medical practice can contribute to differences in renal outcomes in patients with IgA nephropathy. We report the…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Complement Factor I Gene Variant in an Atypical Hemolytic Uremic Syndrome Triggered by Hypereosinophilia Syndrome by Banjongjit, Athiphat, Kittanamongkolchai, Wonngarm, Kanjanabuch, Talerngsak

    Published in Nephron (2015) (01-11-2023)
    “…Atypical hemolytic uremic syndrome (aHUS) is a condition characterized by acute kidney injury (AKI), thrombocytopenia, and microangiopathic hemolytic anemia…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20